Inter Pharma Public Company Limited (IP.BK)
THB 3.42
(6.21%)
THB 3.42
(6.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 98.57 Million | 143.09 Million | -41.57 Million | -8.81 Million | 5.03 Million | -6.18 Million |
| Net Income | 50.78 Million | 147.59 Million | 137.68 Million | 60.49 Million | 47.13 Million | 29.05 Million |
| Depreciation & Amortization | 98.25 Million | 64.83 Million | 26.6 Million | 5.09 Million | 2.06 Million | 1.84 Million |
| Deferred income taxes | - | - | - | 16.7 Million | 13.82 Million | 11.21 Million |
| Stock-based compensation | - | - | - | -12.17 Million | -10.71 Million | - |
| Change in working capital | -59.9 Million | -79.94 Million | -195.08 Million | -79.1 Million | -47.81 Million | -38.92 Million |
| Other non-cash items | 9.43 Million | 10.6 Million | -10.77 Million | 172.11 Thousand | 544.46 Thousand | -9.38 Million |
| Investing Cash Flow | -227.74 Million | -588.13 Million | -351.78 Million | -249.73 Million | -2.04 Million | -7.57 Million |
| Investments in PPE | -144.09 Million | -49.97 Million | -237.84 Million | -14.5 Million | -2.18 Million | -9.21 Million |
| Acquisitions | 6.24 Million | -538.44 Million | -106.77 Million | -235.35 Million | 3177.56 | 2.38 Million |
| Investment purchases | -89.9 Million | -24.61 Thousand | -10.03 Million | -666.62 Thousand | -15.45 Thousand | -828.41 Thousand |
| Sales/Maturities of investments | - | - | -10.87 Million | 6.25 Million | 12.27 Thousand | - |
| Other Investing Activities | 5000.00 | 309.67 Thousand | 13.74 Million | -5.46 Million | 137.84 Thousand | 1.64 Million |
| Financing Cash Flow | -235.03 Million | 1.04 Billion | 414.91 Million | 68.22 Million | 307.2 Million | 10.13 Million |
| Debt repayment | -135.15 Million | -191.74 Million | -23.19 Million | -1.97 Million | -8.4 Million | -62.34 Thousand |
| Dividends payments | -67 Million | - | -4.82 Million | -38.01 Million | -11.57 Million | -28 Million |
| Common Stock Repurchased | - | - | 251.32 Million | - | - | -0.03 |
| Common Stock Issuance | - | 1.04 Billion | 192.21 Million | - | 321.63 Million | 26.6 Million |
| Other Financing Activities | -32.88 Million | 196.45 Million | -611.56 Thousand | 108.22 Million | 318.77 Million | 11.59 Million |
| Accounts receivables | -43.82 Million | -43.02 Million | -138.35 Million | -45.89 Million | -24.45 Million | -46.9 Million |
| Accounts payables | 10.14 Million | 26.32 Million | 35.2 Million | -4.6 Million | -29.61 Million | 49.01 Million |
| Inventory | -25.03 Million | -60.61 Million | -85.31 Million | -27.53 Million | 5.13 Million | -41.06 Million |
| Other working capital | -1.19 Million | -2.63 Million | -6.62 Million | -1.07 Million | 1.12 Million | 2.14 Million |
| Cash at beginning of period | 776.42 Million | 173.86 Million | 152.32 Million | 342.64 Million | 32.44 Million | 36.08 Million |
| Cash at end of period | 412.39 Million | 776.42 Million | 173.86 Million | 152.32 Million | 342.64 Million | 32.44 Million |
| Capital Expenditure | -144.09 Million | -49.97 Million | -237.84 Million | -14.5 Million | -2.18 Million | -9.21 Million |
| Effect of forex changes on cash | 170.83 Thousand | -255.35 Thousand | -14.72 Thousand | - | 1.36 | 0.90 |
| Net cash flow / Change in cash | -364.03 Million | 602.55 Million | 21.53 Million | -190.31 Million | 310.19 Million | -3.63 Million |
| Free Cash Flow | -45.51 Million | 93.12 Million | -279.42 Million | -23.31 Million | 2.85 Million | -15.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.41 Million | 15.79 Million | -14.29 Million | 50.78 Million | 21.46 Million | 19.5 Million |
| Depreciation & Amortization | 27.63 Million | 26.22 Million | 24.39 Million | 98.25 Million | 26.2 Million | 24.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.27 Million | -1.49 Million | 29.18 Million | -59.9 Million | -30.71 Million | -63.24 Million |
| Other non-cash items | 55.36 Million | 66.43 Million | 414.73 Thousand | 9.43 Million | -3.62 Million | -8.64 Million |
| Investing Cash Flow | -39.99 Million | -56.72 Million | -90.99 Million | -227.74 Million | -31.15 Million | -87.06 Million |
| Investments in PPE | -40.12 Million | -57.36 Million | -51.14 Million | -144.09 Million | -31.57 Million | -37.54 Million |
| Acquisitions | 136 Thousand | 641 Thousand | 28 Thousand | 6.24 Million | 6.2 Million | - |
| Investment purchases | -10 Thousand | - | -39.87 Million | -89.9 Million | -23 Thousand | -50 Million |
| Sales/Maturities of investments | -1000.00 | 1000.00 | 3.58 Million | - | -6.2 Million | - |
| Other Investing Activities | -4.17 Million | -11.02 Million | -3.58 Million | 5000.00 | 441 Thousand | 477 Thousand |
| Financing Cash Flow | -66.77 Million | -23.86 Million | -26.2 Million | -235.03 Million | -29.19 Million | -141.82 Million |
| Debt repayment | -43.89 Million | -14.29 Million | -16.99 Million | -135.15 Million | -28.98 Million | -98.54 Million |
| Dividends payments | -12.96 Million | - | -11.59 Thousand | -67 Million | -10 Thousand | -66.97 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34.7 Million | -6.25 Million | -9.19 Million | -32.88 Million | -204 Thousand | 23.7 Million |
| Accounts receivables | 26.9 Million | -6.01 Million | -45.33 Million | -43.82 Million | -18.44 Million | 16.4 Million |
| Accounts payables | -17.95 Million | 2.8 Million | 33.01 Million | 10.14 Million | -14.65 Million | -20.84 Million |
| Inventory | -5.34 Million | 64 Thousand | 40.56 Million | -25.03 Million | -3.27 Million | -55.33 Million |
| Other working capital | -4.87 Million | 1.64 Million | 948.44 Thousand | -1.19 Million | 5.66 Million | -3.47 Million |
| Cash at beginning of period | 383.31 Million | 412.39 Million | 489.88 Million | 776.42 Million | 536.87 Million | 793.15 Million |
| Cash at end of period | 310.05 Million | 383.31 Million | 412.39 Million | 412.39 Million | 489.88 Million | 536.87 Million |
| Capital Expenditure | -40.12 Million | -57.36 Million | -51.14 Million | -144.09 Million | -31.57 Million | -37.54 Million |
| Effect of forex changes on cash | 38 Thousand | 149 Thousand | 4833.00 | 170.83 Thousand | 19 Thousand | 134 Thousand |
| Net cash flow / Change in cash | -73.25 Million | -29.07 Million | -77.49 Million | -364.03 Million | -46.99 Million | -256.27 Million |
| Free Cash Flow | -6.64 Million | -6 Million | -11.44 Million | -45.51 Million | -18.23 Million | -65.06 Million |
LVVEF
AURWF
3600
603060
QCXGF
3662